Paclitaxel: a unique tubulin interacting anticancer agent.
Vyas
D M
DM
Bristol-Myers Squibb Company, Pharmaceutical Research Institute, Wallingford, CT 06492-7660, USA.
Kadow
J F
JF
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015195:Drug Design; D017239:Paclitaxel / Q000031:analogs & derivatives / Q000737:chemistry / Q000627:therapeutic use*; D011355:Prodrugs; D013329:Structure-Activity Relationship; D014404:Tubulin / Q000187:drug effects*
D000970:Antineoplastic Agents; D011355:Prodrugs; D014404:Tubulin; D017239:Paclitaxel